Clinical trial
Does Allopurinol Regress Left Ventricular Hypertrophy in Patients With Treated Essential Hypertension?
NCT02237339 is registered in ClinicalTrials.gov with University of Dundee as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Allopurinol Regress Left Ventricular Hypertrophy in Patients With Treated Essential Hypertension?
- Lead sponsor
- University of Dundee
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- June 30, 2017
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.